Societal Debates About Emerging Genetic Technologies: Toward a Science of Public Engagement
By Christopher D. Wirz,
Environmental Communication
| 09. 29. 2020
Gene editing is an inherently wicked problem
Societal debates about the applications of novel gene editing techniques like CRISPR in agriculture, wildlife, and humans have only rarely focused on questions that have correct or even factual answers. Of course, many discussions within the bench scientific community are focused on technical risks and benefits and the weighing of the latter against the former in the desire to develop climate- or pest-resistant crops (National Academies of Sciences, 2016) or therapies for devastating genetically-inherited diseases in humans (National Academy of Sciences & National Academy of Medicine, 2017).
While public debates are ideally informed by these scientific considerations, they are – by nature – much broader in scope. Gene drives developed to limit the spread of vector-borne illness carried by mosquitos, for instance, have raised concerns about the morality of “messing with nature” by editing the genome of living organisms for dominant traits, about creating imbalances in already fragile ecosystems, and about unintended and potentially irreversible long-term consequences for humans and nature (Brossard et al., 2019). At the same time, pesticides...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...